General Information of Drug (ID:
DR2192) |
Drug Name |
Dithiazoline
|
Synonyms |
dithiazoline |
Indication |
Gonococcal infection
[ICD11: 1A70]
|
Investigative
|
[1]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
105.19 |
Topological Polar Surface Area |
63 |
Heavy Atom Count |
5 |
Rotatable Bond Count |
0 |
Hydrogen Bond Donor Count |
0 |
Hydrogen Bond Acceptor Count |
3 |
Cross-matching ID |
- PubChem CID
- 17990703
- CAS Number
-
- Formula
- C2H3NS2
- Canonical SMILES
- C1C=NSS1
- InChI
- 1S/C2H3NS2/c1-2-4-5-3-1/h1H,2H2
- InChIKey
- WPEVFLXBCFUSFF-UHFFFAOYSA-N
|
|
|
|
|
|
|
|
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug |
DME Name |
DME Info |
Species |
Uniprot ID |
EC Number |
REF |
L,D-carboxypeptidase A (ldcA)
|
DME1200
|
Escherichia coli
|
|
|
[1]
|
L,D-carboxypeptidase A (ldcA)
|
DME1199
|
Neisseria gonorrhoeae
|
|
|
[1]
|
|
|
|
|
|
|
|
References |
1 |
Selective inhibition of Neisseria gonorrhoeae by a dithiazoline in mixed infections with Lactobacillus gasseri. Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e00826-18.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.